We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
-17.38%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$384B
AUM Growth
-$94.8B
Cap. Flow
+$8.65B
Cap. Flow %
2.26%
Top 10 Hldgs %
21.29%
Holding
4,292
New
103
Increased
3,113
Reduced
564
Closed
177

Sector Composition

Rank Sector Weight
1 Technology 22.12%
2 Healthcare 15.34%
3 Financials 13.68%
4 Consumer Discretionary 9.77%
5 Communication Services 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTEK icon
3801
Fuel Tech
FTEK
$47.7M
$77K ﹤0.01%
193,817
ICCC icon
3802
ImmuCell
ICCC
$100M
$77K ﹤0.01%
+20,434
New +$101K
LIVE icon
3803
Live Ventures
LIVE
$29M
$77K ﹤0.01%
15,141
+299
+2% +$1.87K
MBRX icon
3804
Moleculin Biotech
MBRX
$2.89M
$77K ﹤0.01%
56
FUSB icon
3805
First US Bancshares
FUSB
$89.3M
$76K ﹤0.01%
12,507
+632
+5% +$6.46K
RDHL
3806
Redhill Biopharma
RDHL
$3.94M
$76K ﹤0.01%
17
ENT
3807
DELISTED
Global Eagle Entertainment Inc.
ENT
$76K ﹤0.01%
19,494
FOCL
3808
EDAP TMS S.A.
FOCL
$238M
$75K ﹤0.01%
33,404
RAIL icon
3809
FreightCar America
RAIL
$280M
$75K ﹤0.01%
81,534
SEEL
3810
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$75K ﹤0.01%
40
DARE icon
3811
Dare Bioscience
DARE
$20.1M
$74K ﹤0.01%
7,352
-4,653
-39% -$62.6K
CHRN
3812
ChronoScale Holdings
CHRN
$3.55B
$74K ﹤0.01%
1,762
JSPRW icon
3813
Japer Therapeutics Warrants
JSPRW
$164K
$74K ﹤0.01%
+119,750
New +$94.1K
HSTO
3814
DELISTED
Histogen Inc. Common Stock
HSTO
$74K ﹤0.01%
1,195
-127
-10% -$9.91K
LWAY icon
3815
Lifeway Foods
LWAY
$449M
$73K ﹤0.01%
38,539
+511
+1% +$1.12K
CSPI icon
3816
CSP Inc
CSPI
$84M
$72K ﹤0.01%
+20,730
New +$122K
DBVT
3817
DBV Technologies
DBVT
$811M
$72K ﹤0.01%
1,860
-1,040
-36% -$93.3K
BKEP
3818
DELISTED
Blueknight Energy Partners L.P.
BKEP
$72K ﹤0.01%
78,793
+6,136
+8% +$6.37K
FSTX
3819
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$71K ﹤0.01%
19,334
SQBG
3820
DELISTED
Sequential Brands Group, Inc.
SQBG
$71K ﹤0.01%
8,750
+138
+2% +$1.48K
GFI icon
3821
Gold Fields
GFI
$30.5B
$69K ﹤0.01%
14,690
-43,564
-75% -$266K
GLMD icon
3822
Galmed Pharmaceuticals
GLMD
$4.75M
$69K ﹤0.01%
111
PRTH icon
3823
Priority Technology Holdings
PRTH
$553M
$69K ﹤0.01%
35,642
+3,481
+11% +$8.51K
VRDN icon
3824
Viridian Therapeutics
VRDN
$2.3B
$69K ﹤0.01%
10,315
TRIL
3825
DELISTED
Trillium Therapeutics Inc.
TRIL
$69K ﹤0.01%
17,248
-85,477
-83% -$323K

Similar funds

Geode Capital Management's Q1 2020 Portfolio in Review

As of Q1 2020, Geode Capital Management held 4,292 positions worth $384B, down 20% from $478B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Geode Capital Management's Q1 2020 filing shows 103 new, 3,113 increased, 564 reduced and 177 closed positions. Its largest new stake was Perdoceo Education: 1,042,040 shares worth $11.2M. The largest sale was Wellcare Health Plans, Inc., an estimated $248M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Geode Capital Management's largest Q1 2020 buy was Perdoceo Education: 1,042,040 shares worth $11.2M.
  • Geode Capital Management added most to Apple in Q1 2020, an estimated $499M increase.
  • Geode Capital Management's biggest Q1 2020 reduction was Procter & Gamble, cutting an estimated $122M.
  • Geode Capital Management fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $248M.
  • Geode Capital Management's ten largest holdings make up 21% of its $384B portfolio in Q1 2020.
  • Geode Capital Management opened 103 new positions and closed 177 in Q1 2020.
  • Geode Capital Management's portfolio value fell 20% quarter-over-quarter to $384B.

Based on Geode Capital Management's 13F filing for Q1 2020, filed 14 May 2020.